NOS3 Gene Variants and Heart Disease Risk Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on cardiovascular genetics and heart health. Browse all Heart & Cardiovascular Health education

The NOS3 gene encodes endothelial nitric oxide synthase (eNOS), the enzyme that produces nitric oxide in the lining of your blood vessels. Nitric oxide is one of the body’s master signals for vascular health: it relaxes vessel walls, keeps blood flowing smoothly, and limits the stickiness and inflammation that lead to plaque. Because NOS3 sits at the center of that process, common variations in this gene have become a focus of cardiovascular genetics research.

What the NOS3 Gene Does

NOS3 builds eNOS, an enzyme expressed mainly in the endothelium — the single-cell layer that lines every artery and vein. eNOS converts the amino acid L-arginine into nitric oxide, a short-lived gas that diffuses into the surrounding muscle and tells vessels to dilate. This vasodilation lowers vascular resistance, supports healthy blood pressure, and improves oxygen delivery during exertion.

Nitric oxide also does quieter work: it discourages platelets from clumping, reduces adhesion of inflammatory cells to the vessel wall, and helps keep the endothelium in a non-sticky, anti-clotting state. When eNOS output falls — a condition called endothelial dysfunction — those protective effects weaken, and this is considered one of the earliest measurable steps toward atherosclerosis.

Common NOS3 Variants and Their Effects

Three NOS3 variants dominate the research literature. The Glu298Asp variant (rs1799983) changes a single amino acid in the enzyme and has been studied for associations with reduced nitric oxide availability and higher blood pressure in some populations. The -786T>C promoter variant (rs2070744) can lower how much eNOS the gene produces, while a variable-number tandem repeat in intron 4 (the 4a/4b polymorphism) has been linked in meta-analyses to coronary artery disease risk.

Effect sizes for any single variant are modest and vary by ancestry, so no one NOS3 genotype “causes” heart disease. Instead these variants slightly shift the baseline efficiency of the nitric-oxide pathway. That baseline interacts with blood pressure, smoking, exercise, and diet to produce the outcome that actually shows up in a person’s cardiovascular health.

NOS3, Endothelial Function, and Heart Disease Risk

Because eNOS-derived nitric oxide keeps vessels flexible and non-inflamed, reduced NOS3 activity is associated in research with hypertension, endothelial dysfunction, and, in some studies, a higher likelihood of coronary artery disease and related events. The pathway also connects to exercise capacity: nitric oxide signaling drives the blood-flow response to physical activity.

The encouraging part is that the nitric-oxide pathway is highly responsive to behavior. Regular aerobic exercise, adequate dietary nitrate from vegetables, healthy body weight, and not smoking are all associated with better endothelial function — which can partly offset a less-efficient genetic baseline. This is why NOS3 is often taught as a textbook example of gene-environment interaction.

What the Research Shows

Meta-analyses pooling thousands of participants have reported associations between NOS3 variants and hypertension, coronary artery disease, and pregnancy-related vascular conditions, though results differ across ethnic groups and study designs. The consistent theme is that NOS3 modulates risk rather than determining it.

Researchers emphasize interpreting NOS3 in context. A variant that trims nitric-oxide output matters more in someone who is sedentary and hypertensive than in someone who is active with well-controlled blood pressure. Genetics sets a tendency; daily physiology decides much of the outcome.

What Your PlexusDx Results Reveal

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in pathways tied to vascular signaling and metabolism. Rather than predicting whether you will develop heart disease, it maps pathway-level tendencies — the kind of upstream biology that genes like NOS3 help shape — so you and a qualified provider can put your numbers in context.

That context is most useful for prioritizing the modifiable levers that govern endothelial health: movement, nutrition, blood-pressure monitoring, and follow-up testing. PlexusDx tells you about your biology; it does not diagnose cardiovascular disease or tell you what to put in your body.

Frequently Asked Questions

What does the NOS3 gene do?

The NOS3 gene encodes endothelial nitric oxide synthase (eNOS), the enzyme that makes nitric oxide in blood-vessel linings. Nitric oxide relaxes vessels, supports healthy blood pressure, and keeps the endothelium non-sticky and anti-inflammatory. Reduced eNOS activity is an early step toward endothelial dysfunction and atherosclerosis.

Does a NOS3 variant mean I will get heart disease?

No. NOS3 variants such as Glu298Asp or -786T>C modestly shift nitric-oxide pathway efficiency, not your fate. Blood pressure, exercise, smoking, and diet interact with your genetic baseline. Many carriers never develop heart disease, and lifestyle strongly influences endothelial function regardless of genotype.

Can genetic testing predict my heart disease risk?

Genetic testing offers pathway-level context, not a diagnosis or a risk verdict. The PlexusDx Precision Peptide Genetic Test maps tendencies in vascular and metabolic pathways to inform conversations with your provider. It does not diagnose, treat, or predict cardiovascular events, which require clinical evaluation.

Can I improve nitric oxide function naturally?

The nitric-oxide pathway responds strongly to behavior. Regular aerobic exercise, dietary nitrate from vegetables, a healthy weight, and not smoking are associated with better endothelial function. These habits can partly offset a less-efficient NOS3 baseline. Discuss a personalized plan with a qualified healthcare provider.

Want to see how your own biology maps to these pathways? Take the Precision Peptide Genetic Test to explore your pathway-level genetic insights and bring them to your next provider visit.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Heart & Cardiovascular Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.